| |
| |
| Exchange: |
OTC Bulletin Board |
| Security
Type: |
Common |
| Shares
Out: |
13,640,000 |
| Market
Cap: |
10.78(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.79 - $0.79 |
|
| Level
I Sector: |
Industrials |
| Level
II Sector: |
Diversified Services |
| Level
III Sector: |
Business Services |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Sonnet BioTherapeutics Holdings is a clinical-stage biopharmaceutical company with a proprietary technology for developing biologic medicines it refers to as FHAB (Fully Human Albumin Binding). Co. has a pipeline of therapeutic compounds focused primarily on oncology indications of unmet medical need, including SON-080, a low-dose formulation of Interleukin 6 which is in development for Chemotherapy Induced Peripheral Neuropathy; SON-1010, which is being developed for solid tumor indications, including non-small cell lung cancer and head and neck cancer, as well as for antiviral applications; and SON-1210, which is being developed for solid tumor indications, including colorectal cancer.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
479,855 |
539,855 |
| Total Buy Value |
$0 |
$0 |
$106,550 |
$141,650 |
| Total People Bought |
0 |
0 |
5 |
5 |
| Total Buy Transactions |
0 |
0 |
6 |
7 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-08 |
2023-11-07 |
2023-05-09 |
2022-05-09 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Pruitt Michael |
CEO, Chairman |
• • – |
2018-09-27 |
4 |
A |
$11.00 |
$330 |
I/I |
30 |
330 |
|
- |
|
| Pruitt Michael |
CEO, Chairman |
• • – |
2018-09-12 |
4 |
A |
$2.34 |
$702 |
I/I |
300 |
12,062 |
|
- |
|
| Pruitt Michael |
CEO, Chairman |
• • – |
2018-08-16 |
4 |
A |
$11.00 |
$1,100 |
I/I |
100 |
300 |
|
- |
|
| Spitcaufsky Larry |
|
• • • |
2018-06-05 |
4 |
S |
$3.10 |
$18,901 |
I/I |
(6,000) |
87,689 |
|
- |
|
| Spitcaufsky Larry |
|
• • • |
2018-06-04 |
4 |
S |
$3.02 |
$9,110 |
I/I |
(3,000) |
93,689 |
|
- |
|
| Spitcaufsky Larry |
|
• • • |
2018-05-31 |
4 |
S |
$3.03 |
$3,030 |
I/I |
(1,000) |
96,689 |
|
- |
|
| Spitcaufsky Larry |
|
• • • |
2018-05-30 |
4 |
S |
$3.06 |
$3,060 |
I/I |
(1,000) |
97,689 |
|
- |
|
| Spitcaufsky Larry |
|
• • • |
2018-05-29 |
4 |
S |
$3.02 |
$5,416 |
I/I |
(1,775) |
98,689 |
|
- |
|
| Spitcaufsky Larry |
|
• • • |
2018-05-25 |
4 |
S |
$3.11 |
$1,477 |
I/I |
(475) |
100,464 |
|
- |
|
| Spitcaufsky Larry |
|
• • • |
2018-05-21 |
4 |
S |
$3.19 |
$5,628 |
I/I |
(1,750) |
100,939 |
|
- |
|
| Spitcaufsky Larry |
|
• • • |
2018-05-17 |
4 |
S |
$3.35 |
$6,700 |
I/I |
(2,000) |
102,689 |
|
- |
|
| Pruitt Michael |
CEO, Chairman |
• • – |
2018-05-17 |
4 |
A |
$10.50 |
$1,050 |
I/I |
100 |
200 |
|
- |
|
| Spitcaufsky Larry |
Director |
– • • |
2018-05-09 |
4 |
A |
$3.50 |
$245,000 |
I/I |
70,000 |
40,000 |
|
- |
|
| Pruitt Michael |
CEO, Chairman |
• • – |
2018-05-08 |
4 |
B |
$3.50 |
$5,250 |
I/I |
1,500 |
11,672 |
2.58 |
- |
|
| Pruitt Michael |
CEO, Chairman |
• • – |
2018-03-30 |
4 |
B |
$3.70 |
$25,001 |
I/I |
6,757 |
10,262 |
2.66 |
- |
|
| Spitcaufsky Larry |
|
• • • |
2018-01-18 |
4 |
A |
$0.00 |
$0 |
I/I |
10,000 |
16,738 |
|
- |
|
| Spitcaufsky Larry |
|
• • • |
2018-01-18 |
4 |
D |
$0.00 |
$0 |
I/I |
(10,000) |
0 |
|
- |
|
| Kraut Gregory Evan |
Director |
– • – |
2017-12-15 |
4 |
A |
$3.06 |
$352 |
D/D |
115 |
30,517 |
|
- |
|
| Spitcaufsky Larry |
|
• • • |
2017-12-13 |
4 |
A |
$0.00 |
$0 |
I/I |
4,689 |
74,689 |
|
- |
|
| Kraut Gregory Evan |
Director |
– • – |
2017-12-13 |
4 |
A |
$2.61 |
$12,505 |
D/D |
4,511 |
30,402 |
|
- |
|
| Pruitt Michael |
CEO, Chairman |
• • – |
2017-09-26 |
4 |
B |
$1.96 |
$196 |
I/I |
100 |
1,990 |
2.58 |
- |
|
| Kraut Gregory Evan |
Director |
– • – |
2017-09-07 |
4 |
A |
$3.01 |
$1,496 |
D/D |
497 |
25,891 |
|
- |
|
| Pruitt Michael |
CEO, Chairman |
• • – |
2017-09-07 |
4 |
B |
$2.25 |
$225 |
I/I |
100 |
1,870 |
2.58 |
- |
|
| Pruitt Michael |
CEO, Chairman |
• • – |
2017-08-17 |
4 |
B |
$2.60 |
$390 |
I/I |
150 |
1,770 |
2.58 |
- |
|
| Pruitt Michael |
CEO, Chairman |
• • – |
2017-06-15 |
4 |
B |
$2.68 |
$268 |
I/I |
100 |
1,620 |
2.58 |
- |
|
168 Records found
|
|
Page 5 of 7 |
|
|
